Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993;11(3):219-31.
doi: 10.1007/BF00749873.

Growth of cells in a new defined protein-free medium

Affiliations

Growth of cells in a new defined protein-free medium

K Bertheussen. Cytotechnology. 1993.

Abstract

The development of a new stable synthetic serum replacement (SSR) is described, which allows the cultivation of mammalian cells in a defined, protein-free medium containing only dialyzable components. With a low concentration of insulin (RPMI-SR2 medium), growth rates of the transformed cell lines L929, HELA S3, and the hybridoma 1E6 were comparable to growth rates obtained with a serum-containing medium. The same medium also supported long-term cultivation of non-dividing mouse macrophages. The main principle of SSR is a metal ion buffer containing a balanced mixture of iron and trace metals. Stability against precipitation of important metals is achieved by the combined use of EDTA and citric acid as chelating agents. Efficient iron supply is mediated through the inclusion of the compound Aurintricarboxylic acid as a synthetic replacement for transferrin. SSR also contains a growth-promoting surfactant, Pluronic F68. Thus SSR provides a general foundation for growth and differentiation normally provided by serum. Limitations of other serum-free medium designs are discussed here: 1) the inability of transferrin to chelate all metals in the medium; and 2) the use of inorganic iron salts or iron citrate as an iron supplement leads to rapid precipitation of iron hydroxide in the medium. Both these problems are solved in the design of SSR.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell Immunol. 1985 Mar;91(1):143-58 - PubMed
    1. Scand J Immunol. 1987 Jun;25(6):571-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1158-62 - PubMed
    1. Biochem Pharmacol. 1989 Nov 1;38(21):3723-9 - PubMed
    1. Biochem Biophys Res Commun. 1982 Jan 29;104(2):750-7 - PubMed

LinkOut - more resources